Blue Jet Healthcare gets SEBI`s approval to float IPO
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Blue Jet Healthcare has received the Securities and Exchange Board of India’s (SEBI's) approval to float an initial public offering (IPO). The IPO of the company is completely an OFS of up to 21,683,178 equity shares by promoters Akshay Bansarilal Arora and Shiven Akshay Arora.
The company, which filed the draft red herring prospectus with the SEBI in September 2022, got the regulator’s approval on January 11, 2023. Kotak Mahindra Capital Company, ICICI Securities, and J.P. Morgan India are the books running lead managers to the issue. The equity shares are proposed to be listed on BSE and NSE.
The Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
